Dr P Vijay Anand Reddy

Radiation Oncologist

31+ Years Experience

MBBS MD (Radiotherapy) DNB (Radiotherapy) Medical Oncology (ESMO) FUICC FNDM FUICC

Jubilee Hills, Hyderabad

English, Hindi, Telugu

MON-SAT

Overview

Dr Vijay Anand Reddy P: Experienced Radiation Specialist Oncologist in Ameerpet, Archana-Multispeciality-Hospital-Chanda-Nagar, Banjara-Hills, Challa-Hospital, Film-Nagar, Gudimalkapur, Hakimpet, Hi-Tech-City, Humayun-Nagar, Jawahar-Nagar, Hyderabad.

Dr Vijay Anand Reddy P a highly regarded Radiation Specialist Oncologist with 30+ years of experience, practices at Apollo Hospitals Jubilee Hills in Hyderabad. Dr Vijay Anand Reddy P has completed his MBBS, MD (Radiotherapy), DNB (Radiotherapy), Med. Onco., FUICC, FNDM, FUICC. He offers a wide range of services to address various conditions: Brain Tumour, vulvar-cancer, Osteosarcoma Treatment, Salivary Gland Tumours, Mouth cancer, Merkel cell carcinoma, Glioma, Meningioma, Esophageal Cancer, Wilms Tumour, Retinoblastoma, vasc, Breast Lumps, Nonmelanoma skin cancer, Osteosarcoma.

If you’re seeking Radiation Specialist Oncologist in Ameerpet, Archana-Multispeciality-Hospital-Chanda-Nagar, Banjara-Hills, Challa-Hospital, Film-Nagar, Gudimalkapur, Hakimpet, Hi-Tech-City, Humayun-Nagar, Jawahar-Nagar areas of Hyderabad, Dr. Vijay Anand Reddy P is the right choice for expert care and treatment of your Radiation Oncology needs. Book an appointment today and experience top-notch medical care.

Registration No: 10495

Education

As Director of Apollo Cancer Institute Hyderabad, Dr Reddy has been instrumental in the establishment and growth of the institute and its latest entitlement to ‘ Center of Excellence for Cancer’ .

Full Member of American Society of Clinical Oncology (ASCO)Full Member of American Society for Radiation Oncology (ASTRO)Permanent Member of European Society of Medical Oncology (ESMO)Permanent Member of &ldquo Union for International Cancer Control&rdquo , UICC, GenevaPresident of Association of Radiation Oncologists of India (AROI)President of Association of Radiation Oncologists of India (AROI), Telangana ChapterPresident of Association of Radiation Oncologists of India (AROI), AP Chapter (Past)Member of Indian College of Radiation Oncology (ICRO)Chairman, Indian College of Radiation Oncology (ICRO), INDIAMember of Indian Society of Oncology (ISO)Member of Civil Assistant Surgeon& s Association, Andhra PradeshMember of Indian Medical Association (IMA)Member of Indian Co-operative Oncology Network (ICON)Member of Indian Brachytherapy Society (IBS)

Full Member of American Society of Clinical Oncology (ASCO)
Full Member of American Society for Radiation Oncology (ASTRO)
Permanent Member of European Society of Medical Oncology (ESMO)
Permanent Member of Union for International Cancer Control, UICC, Geneva President of Association of Radiation Oncologists of India (AROI)
President of Association of Radiation Oncologists of India (AROI),
Telangana Chapter President of Association of Radiation Oncologists of India (AROI),
AP Chapter (Past)Member of Indian College of Radiation Oncology (ICRO)Chairman, Indian College of Radiation Oncology (ICRO),
INDIA Member of Indian Society of Oncology (ISO)Member of Civil Assistant Surgeon& s Association, Andhra Pradesh Member of Indian Medical Association (IMA)
Member of Indian Co-operative Oncology Network (ICON)Member of Indian Brachytherapy Society (IBS)

Experience

Director & Sr. Consultant, Apollo Cancer Hospital, Hyderabad, since April 2002.
Consultant Ocular Oncologist, L. V. Prasad Eye Institute since 1998.
Stereotactic Radiosurgery Fellowship at Klinikum Frankfurt (Oder) GmbH, Frankfurt, Germany, March 2010.
Ocular Oncology Fellowship at Children’s Hospital of Philadelphia, USA & Will’s Eye Hospital, Philadelphia, USA, May-June 2003.
Head & Neck Oncology Fellowship: Peter MacCallum Cancer Institute, Melbourne, Australia, July-August 1998.
Head & Neck Brachytherapy Observership: The Memorial Sloan Kettering Cancer Centre, New York, June 1995.
Nargis Dutt Memorial Cancer Foundation Fellowship: The New York Hospital, Medical Centre of Queens, New York, May-July 1995.
Clinical Observership: Christie Hospital, Manchester, United Kingdom, Sept 1992.
Clinical Oncology Fellowship: The Meyerstein Institute of Oncology, The Middle Sex Hospital, London, July-Sept 1992.
Associate Professor of Radiation Oncology, Kakatiya Medical College, Warangal, April 1999-April 2001.
Assistant Professor, MNJ Institute of Oncology, Red Hills, Hyderabad, April 1992-1999.
Clinical Oncology Fellowship: Adyar Cancer Institute, Chennai, Jan 1990.
Medical Oncology Fellowship: Nizam Institute of Medical Sciences, Hyderabad, Sept 1990.
Radiation Oncology Fellowship: Tata Memorial Hospital, Mumbai, March-August 1990.
Elected as the Chairman ICRO (Indian College of Radiation Oncology), a prestigious body, December 2012.

Doctor Awards

Dr. Vijay Anand Reddy has been awarded as &ldquo
The Legend in the Field of Oncology&rdquo at the Times Healthcare Achievers Awards function at HICC, Hyderabad on 28th Feb& 2017.
Best Scientific Paper Award 2015&rdquo for Prospective study of Neurocognitive function, performance status, quality of life and local control in patients with 1-3 newly diagnosed brain metastases treated with stereotactic radio surgery alone Awarded by AROICON 2015, Lucknow, INDIA
Best Scientific Paper Award 2014&rdquo for A Prospective Observational Feasibility Study of Hypofractionated Radiotherapy for Clinically localized Carcinoma Prostate Awarded by AROICON 2014, Imphal, INDIA
American Academy of Ophthalmology Achievement Award Best Scientific Paper Award 2009&rdquo for Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors Awarded by AROICON 2009, Hyderabad, INDIA&ldquo
Best Scientific Poster Award 2009&rdquo for Histopathology of Retinoblastoma after primary Chemotherapy Awarded by AROICON 2009, Hyderabad,
INDIA&ldquo BEST POSTER&rdquo AWARD 2008 Awarded by American Academy of Ophthalmology at Atlanta, GA, USA&ldquo
YOUNG INVESTIGATORS AWARD&rdquo 2001 Awarded at New Delhi by Eli Lilly & Company, USA&ldquo INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD&rdquo Awarded in 1998 by UICC, Geneva, Switzerland&ldquo
YOUNG SCIENTIST AWARD&rdquo 1996 Awarded by Indo-American Cancer Congress, New York, USA&ldquo
BEST SCIENTIFIC PAPER AWARD&rdquo 1996 at XVIII National Conference of Assoc.
Oncologists of India&rdquo at Aurangabad&ldquo
NARGIS DUTT MEMORIAL FOUNDATION AWARD&rdquo 1995 Awarded by Nargis Dutt Memorial Foundation, Flushing, New York&ldquo
INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD&rdquo Awarded in 1992 by UICC, Geneva, Switzerland.
Presentations of Cancer: Invited as a Panelist for the &ldquo Gynecological Session&rdquo at Best of ASCO 2017, Chandigarh from July 14-16, 2017.
Invited as a Panelist for the &ldquo Lung Session&rdquo at Best of ASCO 2017, Chandigarh from July 14-16, 2017. Invited as a Chairperson for the Panel discussion on &ldquo Opening the Lid for Bevacizumab in Gynecological Malignancies&rdquo CME Organized by Intas Oncology, Hyderabad on July 12, 2017.
Invited as a Chairperson for the Session on &ldquo Expert talk in NSCLC&rdquo CME Organized by Novartis Oncology, Hyderabad on June 13, 2017. &ldquo Radiotherapy in Retinoblastoma&rdquo at Retinoblastoma Networking Workshop, LVPEI,
Hyderabad from June 10-12, 2017. &ldquo Breast&rdquo at Best of ASTRO 2017,
Vizag on May 13-14, 2017. &ldquo Bilateral Breast using TomoTherapy&rdquo at Accuray User& s Meeting,
Bangalore on April 22-23, 2017. &ldquo Re-irradiation When and how to?&rdquo Session on &ldquo
Novel therapies Part III Molecular Neuro-Oncology Resistance and re-treatment&rdquo at 9th annual Conference of Indian Society of Neuro-Oncology (ISNOCON 2017), Bangalore from January 10-12, 2017. &ldquo Crossfire: Surgery vs Radiotherapy for high risk early Prostate Cancer&rdquo at First Prostate Cancer Symposium PRiSM 2016 organized by Dr. Reddy& s Laboratories Ltd. ,
Hyderabad from December 17-18, 2016. &ldquo Optimal treatment for oligo brain metastasis: Role of SRS&rdquo Session on &ldquo CNS Debate (Debator – 1 in favour of SRS)&rdquo at 39th AROICON 2016,
Bhubaneshwar from November 24-27, 2016. &ldquo Plaque Brachytherapy for Ocular Tumor&rdquo Session on &ldquo Paediatrics Oncology&rdquo at 39th AROICON 2016, Bhubaneshwar from November 24-27, 2016. &ldquo Ocular Brachytherapy&rdquo at AROICON – 2016, TN-PY Chapter,
Chennai on October 15-16, 2016. &ldquo Cancer Management Paradigm Shift&rdquo at Recent Advances in Surgical Procedures,
Dubai UAE on September 30, 2016. &ldquo Organ Preservation Protocols our experience&rdquo at FHNO South-East Zonal CME on Ca. Larynx, Organized by Apollo Cancer Institute in association with AOI Hyderabad & Telangana State Branches, Hyderabad on September 3, 2016. &ldquo Brachytherapy in Ophthalmic
Tumors&rdquo at 6th Annual Conference of IBSCON 2016, Hyatt Regency, Chennai on August 27-28, 2016. &ldquo Radiotherapy in Elderly Breast Cancer&rdquo Session on &ldquo Breast Cancer in Elderly: Coming of Age&rdquo at Navigating Clinical Conundrums in Breast Cancer, Mumbai on August 20-21, 2016.
&ldquo Overall Scenario of Cancer in India & Prevention & Cure&rdquo Session on &ldquo Cancer Prevention & A Healthy Lifestyle&rdquo at CII Young Indians, Hyderabad on July 28, 2016.
Invited as a Perspective for &ldquo Hard Talk – Perspective in adopting new data&rdquo Session on &ldquo Irradiating the axilla- Why exchange one toxicity for another especially when prognostication is at stake?&rdquo at Controversies in Clinical Oncology, TMH,
Kolkata from July 22-24, 2016. &ldquo New Technology Does it have an impact in the management of Gynaec Cancers Cost vs benefit&rdquo at CME on &ldquo Oncology and Robotics in Gynecology&rdquo , organized by OGSH in association with Apollo Hospitals, Hyderabad on July 16, 2016.
Invited as a Panelist for the Panel discussion on &ldquo Case Based Discussion in Rare Solid Tumors&rdquo at 3rd Mid Term National Conference of Pediatric Hematology Oncology, Hyderabad on July 9-10, 2016.
&ldquo Role of Radiation Oncologist in the Management of Ophthalmic Tumors&rdquo , at EYE CANcer 2016, LVPEI, Hyderabad on July 9, 2016.
Moderator for the Panel Discussion on &ldquo Lung Cancer Non-small Cell / Small Cell / Other&rdquo at Best of ASCO 2016, HICC, Hyderabad on July 1-3, 2016.
Moderator for the Session on &ldquo Each Expert Group Propose Recommendations&rdquo at CME on &ldquo Consensus Recommendations of Expert Group for Management of Advanced Cervical Cancer in India&rdquo , organized by Roche Oncology, Hyderabad on June 18, 2016. &ldquo Cancer Management A Paradigm Shift&rdquo , CME Program on Post Thrombotic Syndrome and Varicose Vein Ulcer Management organized by Apollo Hospitals, Hyderabad in association with IMA, East at Hyderabad on April 24, 2016.
Moderator for the Panel Discussion &ldquo Decision Making for Adjuvant Radiation&rdquo Session on &ldquo Breast Cancer 1: Early Breast Cancer&rdquo at 12th International Conference of Asian Clinical Oncology Society (ACOS), New Delhi from April 8-10, 2016.
Invited as a Chairperson for &ldquo Direction of Current Neuro-oncology Research&rdquo at ISNOCON 2016, Hyderabad from April 1-3, 2016.
Invited as a Panelist for the Head and Neck Cancer& Session on &ldquo Therapeutic Decision Making in Borderline and locally advanced HNSCC&rdquo at 34th ICON (Joint Conference of Indian Cooperative Oncology Network and Molecular Oncology Society, Hyderabad from March 11-13, 2016.
Invited as a Panelist for the Lunch Symposium on &ldquo Challenges in delivery of chemoradiation in Lung Cancer&rdquo at 34th ICON (Joint Conference of Indian Cooperative Oncology Network and Molecular Oncology Society, Hyderabad from March 11-13, 2016. &ldquo Did the higher accuracy in treatment delivery translate into noticeable Clinical Improvements?&rdquo at AROI West Bengal Annual State Conference,
Kolkata on February 20-21, 2016. &ldquo Cancer Management Paradigm Shift&rdquo at Indian Medical Association (IMA) CME, Hyderabad on February 13, 2016. Invited as a Panelist for the Panel Discussion on &ldquo Nanotechnology based Paclitaxel in Clinical Practice&rdquo at SUN Oncology BEVETEX Symposium, Hyderabad on January 2, 2016.

Research

A retrospective analysis of irinotecan and bevacizumab combination therapy in recurrent high-grade glioma and glioblastoma multiforme: Single Institute experience – International Journal of Neuro-Oncology; 2022; Vol. 5(1), Pg: 1-9.
Primary Macular Retinoblastoma: Clinical Presentation and Treatment Outcomes – Journal of VitreoRetinal Diseases; Aug 2022; Vol. 6(5), Pg: 367-373.
Does Multimodal Treatment improve Eye and Life Salvage in Adenoid Cystic Carcinoma of the Lacrimal Gland – The American Society of Ophthalmic Plastic and Reconstructive Surgery; 2021.
Use of Bevacizumab in Advanced Ovarian Cancer: Consensus from an Expert Panel Oncologists – Indian Journal of Gynecologic Oncology; 2021.
Histopathology – Guided management of Ocular surface squamous neoplasia with corneal stromal or scleral invasion using Ruthenium – 106 Plaque Brachytherapy – British Journal of Ophthalmology, Dec 2021; Vol. 10, Pg: 1-6.
Outcomes of Tandem Intravitreal Chemotherapy for Refractory Vitreous Seeds in Retinoblastoma – AIOC 2021 Proceedings.
Use of Bevacizumab in Advanced Ovarian Cancer: Consensus from an Expert Panel Oncologists – Indian Journal of Gynecologic Oncology, Feb 2021; Vol. 19(25), Pg: 1-8.
Stereotactic Radiosurgery for Single or Oligometastatic Brain Lesions: A single Institutional Experience – Intl. Journal of Neuro-Oncology, Dec 2020; Vol. 3(2), Pg: 93-97.
Second Primary Tumors in Retinoblastoma Survivors: A study of 7 Asian Indian patients – International Ophthalmology, Dec 2020; Vol. 40(2), Pg: 3303-3308.
Ocular Oncology Practice Guidelines during COVID-19 Pandemic – An Expert Consensus – Indian Journal of Ophthalmology, July 2020; Vol. 68(7), Pg: 1281-1291.
Choosing Wisely for Cancer Care in India – Indian Journal of Surgery, February 2020; Vol. 82(1), Pg: 6-8.
Preservation of Retinoblastoma Group E Eyes with Neovascular Glaucoma using Intravenous Chemotherapy: Risk factors and outcomes – British Journal of Ophthalmology, Dec’ 2019; Vol. 103(12), Pg: 1856-1861.
Presented a Poster on “Selective Ophthalmic Artery Chemotherapy as Primary treatment in advanced Stages of Retinoblastoma : A Prospective Study – European Society of Radiology 2019; Poster No.: C-1856; DOI: 10.26044/ecr2019/C-1856; Pg: 1-13.
Choosing Wisely India: Ten low-value or harmful practices that should be avoided in Cancer Care – DOI Handbook, March 2019; Pg: 1-6.
Reducing Gender Disparity in Oncologists of India: An opportunity to Address Workforce Challenges – Journal of Clinical Oncology, August 2018; Pg: 1-5.
Utilization of a Web-based Conferencing Platform to improve Global Radiation Oncology Education and Quality – Proof of Principle through implementation in India – International Journal of Radiation Oncology, July 2018; Vol. 103; No. 1; Pg: 276-280.
Eye Salvage in diffuse Anterior Retinoblastoma using Systemic Chemotherapy with Periocular and Intravitreal Topotecan – Journal of American Association for Pediatric Ophthalmology and Strabismus, April 2018; Vol. 22; No. 3.
Melanorrhea: Noncontiguous spread of palpebral Conjunctival Melanoma to the Nasolacrimal Duct – Indian Journal of Ophthalmology, February 2018; Vol. 66; No. 2; Pg. 302-303.
Re-irradiation in Central Nervous System Tumors – Journal of Current Oncology, Jan-June 2018; Vol. 1; Issue. 1; Pg. 40-42.
Radiobiology of Re-irradiations – Journal of Current Oncology, Jan-June 2018; Vol. 1; Issue. 1; Pg. 35-39.
Management of Retinoblastoma with Extraocular tumor Extension – Community Eye Health Journal, 2018; Vol. 31; No. 101; Pg. 18-19.
Outcomes and Prognostic factors in re-irradiation of Intracranial Gliomas: Single Institution Experience – Annals of Oncology, November 2017; Vol. 28; No. 10.
Intravitreal Topotecan in the Management of Refractory and Recurrent Vitreous seeds in Retinoblastoma – British Journal of Ophthalmology, August 2017; Vol. 102; No. 4.
Aqueous Deficient Dry Eye Syndrome Post Orbital Radiotherapy: A 10-year Retrospective Study – Translational Vision Science & Technology, June 2017; Vol. 6; No. 3; Article 19; Pg. 1-9.
Clinical Presentation and Outcomes of Stage III or Stage IV Retinoblastoma in 8 Asian Indian Patients – Journal of Pediatric Ophthalmology & Strabismus, 2017; Vol. 54; No. 3; Pg. 177-184.
Asian Expert Recommendation on Management of Skin and Mucosal effects of Radiation, with or without the addition of Cetuximab or Chemotherapy, in treatment of Head & Neck Squamous Cell Carcinoma – BMC Cancer, 2016; Vol. 16; No. 42; Pg. 1-13.
Therapy and Lacrimal Drainage System Toxicity: Nasal Localization Studies using Whole body Nuclear Scintigraphy and SPECT-CT – The American Society of Ophthalmic Plastic and Reconstructive Surgery 2014; Vol. XX; No. XX; Pg. 1-4.
Ophthalmologic Pathology: SY20-2 What is your Diagnosis? – Royal College of Pathologists of Australia, Taylor & Francis October 2014; Vol. 46 (2); Pg. S30
Orbital Alveolar soft-part Sarcoma: Clinico-pathological profiles, management and Outcomes – Journal of Cancer Research and Therapeutics; April-June 2014; Vol. 10; Issue. 2; Pg. 294-298.
Management and Outcome of Retinoblastoma with Vitreous Seeds – American Academy of Ophthalmology Feb 2014; Vol. 121 (2); Pg. 517-524
Lacrimal Surgery Glorious past, exciting present era and the audacity of hope for a brilliant future – Saudi Journal of Ophthalmology 2014; Vol. 28; Pg. 1-2.
Gene Expression Signature of Putative Cancer Stem Cells in Retinoblastoma Y79 Cell Line – Investigative Ophthalmology & Visual Science 2013; Vol. 54; E-Abstract 3968.
Evolution of Response to Carboplatin in Putative Cancer Stem Cells of Retinoblastoma Y79 Cell Line – Investigative Ophthalmology & Visual Science 2013; Vol. 54; E-Abstract 1256.
Distant metastatic Retinoblastoma without Central Nervous system involvement – Indian Journal of Ophthalmology July 2013; Vol. 61(7); Pg. 357-359.
Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker – Histopathology May 2013; Vol. 62(6); Pg. 840-846.
Primary Intraocular Malignant Extrarenal Rhabdoid tumor: a Clinicpathological Correlation – Journal of Pediatric Ophthalmology and Strabismus April 2013; Vol. 50; Pg. e18-20.
Distant Metastatic Retinoblastoma without Central Nervous System involvement – Indian Journal of Ophthalmology April 2013; PubMed ID – 23548316.
Optic Nerve Meningeal Hemangiopericytoma: A Clinicopathological Case Report – Survey of Ophthalmology January 2013; pii: S0039-6257(12)00248-2. doi: 10.1016; PubMed ID – 23294915.
Radiation Oncology in 21st Century – Changing the Paradigms – Apollo Medicine June 2012; Vol. 9; No. 2; Pg. 115-125.
Orbital Plasmablastic Lymphoma: A Clinico-Pathological Correlation of a rare disease and review of Literature – Clinical Ophthalmology (Auckland, N.Z.) 6: 2012; Pg. 2049-2057.
Evaluation of HER-2/neu status in Breast Cancer Specimens using Immunohistochemistry (IHC) & Fluorescence in-situ hybridization (FISH) assay – Indian Journal of Medical Research March 2012; Pg. 312-317.
Establishing Human Lacrimal Gland Cultures with Secretory Function – PLoS One. 2012; Vol. 7(1); e29458.
High Dose Rate Interstitial Brachytherapy in Carcinoma Eyelid: Can it be a Primary treatment Modality? – Journal of Cancer Research and Therapeutics Oct-Dec 2011; Vol. 7(4); Pg. 498-499.
First Indian Experience with Shaped Beam Radiosurgery of Cranial and Spinal Lesions on Novalis-Tx Linear Accelerator with Exac Trac 6D Robotic Couch – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1166.
Set-up Accuracy with Frameless Radiosurgery of Intracranial Lesions using Exac Trac 6-D Robotic Couch on Novali-Tx Linear Accelerator – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1147.
Comparison of Intensity Modulated Stereotactic Radiosurgery with Conventional Stereotactic Conformal Beam Radiosurgery in Vestibular Schwannomas – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1003.
The New Radiation Technology and Techniques – Does it Matter in Gynec Cancer? – Annals of IMA Academy of Medical Specialities 2011; Pg. 49-53.
Evaluation of Human Lacrimal Gland Cultures for Secretory Function and Putative Stem Cells – Indian Eye Research Group (IEGR) 2011; Pg. 84.
Orbital Retinoblastoma: Where do we go from here? – Journal of Cancer Research and Therapeutics May 2011; Vol. 7(1); Pg. 11-14.
Cultivation and Characterization of Human Lacrimal Gland Cells for Potential Clinical Application – Indian Eye Research Group (IERG) 2010; Vol. 1; Pg. 80.
Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors – Indian Eye Research Group (IERG) 2010; Vol. 1; Pg. 110-111.
Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors – Shifting Paradigms in Head and Neck Oncology (IFHNOS) 2010; Vol. 1; Pg. 233
Orbital Retinoblastoma: Present status and future challenges – A review – Saudi Journal of Ophthalmology 2010, Vol. 25(2); Pg. 159-167.
Largest series of orbital Schwannoma: Clinical manifestations and outcomes (Abs) – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 131.
Genotype-Phenotype and Clinical Correlation in Retinoblastoma (Abs) – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 129.
RBI Gene Mutations in Ratinoblastoma and its clinical correlation – Saudi Journal of Ophthalmology May 2010; Vol. 24; Pg. 119-123.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcomes in Ocular Tumors (Abs) – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 121.
A typical presentation of Ciliary body Medulloepithelioma (Abs) – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 116.
Histopathology of Retinoblastoma after primary Chemotherapy (Abs) – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 100.
Evisceration in unsuspected Intraocular Tumors – Archives of Ophthalmology March 2010; Vol. 128(3); Pg. 372-379.
Histopathologic changes in Uveal melanoma after Ruthenium 106 Brachytherapy – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S98
Cultivation and characterization of Lacrimal and Salivary Gland Cells for Potential Clinical application – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S98
Role of HPV, Cell cycle markers and epigenetic modifications at DNMT3L region in Ocular surface Squamous Neoplasia – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S97
HPV for Cervical Cancer Screening: Is the era of the Molecular Pap Smear upon us? – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S97
Ruthenium 106 Plaque Brachytherapy : Indications and outcome in Ocular Tumors – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S88-89.
Cervical Cancer Screening: Role of Serotyping of HPV as bridge of Cytopathology and Molecular typing? – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S75
Genotype and phenotype correlation analysis in Retinoblastoma – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S75
Sebaceous Carcinoma of the Eyelid Metastasizing to the Lacrimal Sac after 5 years – Orbit (Amsterdam, Netherlands) October 2009; Vol. 28(5); Pg.309-312.
Histopathology of retinoblastoma after primary chemotherapy – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 296.
Orbital Schwannoma: Clinical manifestations and outcomes – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 146.
Periocular Carboplatin Injection in the management of Retinoblastoma with Diffuse Vitreous Seeds – The International Society of Ocular Oncology ISOO Meetings, Cambridge 2009; Pg. 277.
A typical presentation of Ciliary body Medulloepithelioma – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 46.
Management of Ophthalmic Tumors – Role of Chemotherapy and Radiation therapy – Surgical Atlas of Orbital Diseases July 2009; Chapter. 25; Pg. 307-318.
Histopathologic Risk factors in Retinoblastoma in India – The American Journal of Surgical Pathology May 2009; Vol. 33(5); Pg. 788-798.
Extramedullary Leukemia in Children presenting with Proptosis – Journal of Hematology & Oncology 2009; Vol. 2; Pg. 4.
Retinoblastoma – Advances in Management – Apollo Medicine Sept. 2008; Vol. 5; No. 3; Pg. 183-189.
Proptosis as a Manifestation of Acute Myeloid Leukemia – Pediatric Clinics of North India 2008.
Clinical Profile and Treatment Outcome of Orbital Rhabdomyosarcoma – Experience of An Ocular Oncology Center – Best Paper of Orbit/Plastic Surgery Session – 1 in AIOC 2007 Proceedings, Pg. 417-418.
The Role of Subconjunctival Carboplatin in the Treatment of Advanced Cases of Retinoblastoma – A series of First Ten Patients – Best Paper of Pediatric Ophthalmology Session in AIOC 2007 Proceedings, Pg. 36-40.
Metastasis to the Eye and Orbit from Renal Cell Carcinoma – A Report of Three Cases and Review of Literature – Survey of Ophthalmology Mar-Apr 2007; Vol. 52(2); Pg. 213-223.
Systemic Metastasis Following Hyphema Drainage in an Unsuspected Retinoblastoma – Journal of Pediatric Ophthalmology and Strabismus Mar-Apr 2007; Vol. 44; Pg. 120-123.
Orbital Embryonal Rhabdomyosarcoma in association with Neurofibromatosis type 1 – Ophthalmic Plastic and Reconstructive Surgery Mar-Apr 2007; Vol. 23(2); Pg. 147-148.
Acute Respiratory Distress Syndrome due to Strongyloides Stercoralis in Non-Hodgkin’s Lymphoma – The Indian Journal of Chest Diseases & Allied Sciences Jan-Mar 2006; Vol. 48(1); Pg. 67-69.
Ruthenium-106 Plaque Brachytherapy for the treatment of Diffuse Choroidal Haemangioma in Sturge-Weber Syndrome – Indian Journal of Ophthalmology Dec. 2005; Vol. 53(4); Pg. 274-275.
Neoadjuvant Chemotherapy in the Management of Sebaceous Gland Carcinoma of the Eyelid with Regional Lymph Node Metastasis – Ophthalmic Plastic and Reconstructive Surgery July 2005; Vol. 21(4); Pg. 307-309.
Concurrent Chemo Radiotherapy followed by Intraluminal Brachytherapy in non-metastatic carcinoma oesophagus – Journal of Clinical Oncology, ASCO Annual Meeting Proceedings, Vol. 22, 14S (July 15 Supplement), 2004 : 4201.
Clinicopathologic findings in Choroidal Melanomas after failed Transpupillary Thermotherapy – American Journal of Ophthalmology March 2004; Vol. 137(3); Pg. 594-595; author reply 595-596
Histopathology of Retinoblastoma after Primary Chemotherapy – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 94.
Retinoblastoma in Older Children – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 91.
Adenoid Cystic Carcinoma of the Lacrimal Gland in Asian-Indian Population – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 84.
Management of Orbital Retinoblastoma – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 51.
A Typical Presentation of Retinoblastoma – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 44.
A Case Report of Unknown Orbital Tumor – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 40.
Neoadjuvant Chemotherapy in the Management of Sebaceous Gland Carcinoma – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 38-39.
Thermochemotherapy in hereditary Retinoblastoma – British Journal of Ophthalmology Nov. 2003; Vol. 87(11); Pg. 1432.
Retinoblastoma – Asian Journal of Pediatric Practice 2003.
Retinoblastoma Management – Current Concepts – Chakshu 2003.
Current Management of Retinoblastoma – Eye Care 2003; Pg. 15-19.
Ultrasound guided Conformal Brachytherapy in Prostate Cancer – Journal of Radiotherapy and Oncology, Vol. 58(1) Pg. S109-S110 Proceedings of ISRO – ICRO 2001; 6th International Congress of Radiation Oncology, 30th Jan to 2nd Feb 2001 at Melbourne, Australia.
Low dose rate Intraluminal Brachytherapy following Concurrent Chemo-radiation in Non-metastatic Carcinoma Oesophagus – Journal of Clinical Radiotherapy and Oncology Jul-Dec 1997; Vol. 12(1-2); Pg. 32-35.
A prospective randomized study of the role of combination of Interferon and Radiation therapy in the management of locally advanced Carcinoma Cervix (Stage III B) – A Preliminary Report – Journal of Clinical Radiotherapy and Oncology Jul-Dec 1997; Vol. 12(1-2); Pg. 28-31.
An experience with low dose rate Intraluminal Brachytherapy following Concurrent Chemo radiation in Non-metastatic Carcinoma Oesophagus – Journal of Clinical Oncology 1997; Vol. 43(2).
A prospective randomized study of the role of combination of Interferon and Radiation therapy in the management of locally advanced Carcinoma Cervix (Stage III B) – A Preliminary Report – Journal of Clinical Radiotherapy & Oncology 1997; Vol. 43(2).
Assessment of Pain in Cancer Patients – Journal of Clinical Radiotherapy & Oncology March 1992; Vol. 7(1); Pg. 4-8.
Role of HBI in Symptomatic Multiple Bone Metastases – M.D. Thesis A.P. University of Health Sciences, A.P. Feb 1992.

Dr P Vijay Anand Reddy

Radiation Oncologist

31+ Years Experience

MBBS MD (Radiotherapy) DNB (Radiotherapy) Medical Oncology (ESMO) FUICC FNDM FUICC

English, Hindi, Telugu

MON-SAT

Overview
Doctor Awards

Overview

Registration No: 10495

Education

Full Member of American Society of Clinical Oncology (ASCO)
Full Member of American Society for Radiation Oncology (ASTRO)
Permanent Member of European Society of Medical Oncology (ESMO)
Permanent Member of Union for International Cancer Control, UICC, Geneva President of Association of Radiation Oncologists of India (AROI)
President of Association of Radiation Oncologists of India (AROI),
Telangana Chapter President of Association of Radiation Oncologists of India (AROI),
AP Chapter (Past)Member of Indian College of Radiation Oncology (ICRO)Chairman, Indian College of Radiation Oncology (ICRO),
INDIA Member of Indian Society of Oncology (ISO)Member of Civil Assistant Surgeon& s Association, Andhra Pradesh Member of Indian Medical Association (IMA)
Member of Indian Co-operative Oncology Network (ICON)Member of Indian Brachytherapy Society (IBS)

Experience

Director & Sr. Consultant, Apollo Cancer Hospital, Hyderabad, since April 2002.
Consultant Ocular Oncologist, L. V. Prasad Eye Institute since 1998.
Stereotactic Radiosurgery Fellowship at Klinikum Frankfurt (Oder) GmbH, Frankfurt, Germany, March 2010.
Ocular Oncology Fellowship at Children’s Hospital of Philadelphia, USA & Will’s Eye Hospital, Philadelphia, USA, May-June 2003.
Head & Neck Oncology Fellowship: Peter MacCallum Cancer Institute, Melbourne, Australia, July-August 1998.
Head & Neck Brachytherapy Observership: The Memorial Sloan Kettering Cancer Centre, New York, June 1995.
Nargis Dutt Memorial Cancer Foundation Fellowship: The New York Hospital, Medical Centre of Queens, New York, May-July 1995.
Clinical Observership: Christie Hospital, Manchester, United Kingdom, Sept 1992.
Clinical Oncology Fellowship: The Meyerstein Institute of Oncology, The Middle Sex Hospital, London, July-Sept 1992.
Associate Professor of Radiation Oncology, Kakatiya Medical College, Warangal, April 1999-April 2001.
Assistant Professor, MNJ Institute of Oncology, Red Hills, Hyderabad, April 1992-1999.
Clinical Oncology Fellowship: Adyar Cancer Institute, Chennai, Jan 1990.
Medical Oncology Fellowship: Nizam Institute of Medical Sciences, Hyderabad, Sept 1990.
Radiation Oncology Fellowship: Tata Memorial Hospital, Mumbai, March-August 1990.
Elected as the Chairman ICRO (Indian College of Radiation Oncology), a prestigious body, December 2012.

Doctor Awards

Dr P Vijay Anand Reddy

Dr. Vijay Anand Reddy has been awarded as &ldquo
The Legend in the Field of Oncology&rdquo at the Times Healthcare Achievers Awards function at HICC, Hyderabad on 28th Feb& 2017.
Best Scientific Paper Award 2015&rdquo for Prospective study of Neurocognitive function, performance status, quality of life and local control in patients with 1-3 newly diagnosed brain metastases treated with stereotactic radio surgery alone Awarded by AROICON 2015, Lucknow, INDIA
Best Scientific Paper Award 2014&rdquo for A Prospective Observational Feasibility Study of Hypofractionated Radiotherapy for Clinically localized Carcinoma Prostate Awarded by AROICON 2014, Imphal, INDIA
American Academy of Ophthalmology Achievement Award Best Scientific Paper Award 2009&rdquo for Ruthenium 106 Plaque Brachytherapy: Indications and Outcome in Ocular Tumors Awarded by AROICON 2009, Hyderabad, INDIA&ldquo
Best Scientific Poster Award 2009&rdquo for Histopathology of Retinoblastoma after primary Chemotherapy Awarded by AROICON 2009, Hyderabad,
INDIA&ldquo BEST POSTER&rdquo AWARD 2008 Awarded by American Academy of Ophthalmology at Atlanta, GA, USA&ldquo
YOUNG INVESTIGATORS AWARD&rdquo 2001 Awarded at New Delhi by Eli Lilly & Company, USA&ldquo INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD&rdquo Awarded in 1998 by UICC, Geneva, Switzerland&ldquo
YOUNG SCIENTIST AWARD&rdquo 1996 Awarded by Indo-American Cancer Congress, New York, USA&ldquo
BEST SCIENTIFIC PAPER AWARD&rdquo 1996 at XVIII National Conference of Assoc.
Oncologists of India&rdquo at Aurangabad&ldquo
NARGIS DUTT MEMORIAL FOUNDATION AWARD&rdquo 1995 Awarded by Nargis Dutt Memorial Foundation, Flushing, New York&ldquo
INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD&rdquo Awarded in 1992 by UICC, Geneva, Switzerland.
Presentations of Cancer: Invited as a Panelist for the &ldquo Gynecological Session&rdquo at Best of ASCO 2017, Chandigarh from July 14-16, 2017.
Invited as a Panelist for the &ldquo Lung Session&rdquo at Best of ASCO 2017, Chandigarh from July 14-16, 2017. Invited as a Chairperson for the Panel discussion on &ldquo Opening the Lid for Bevacizumab in Gynecological Malignancies&rdquo CME Organized by Intas Oncology, Hyderabad on July 12, 2017.
Invited as a Chairperson for the Session on &ldquo Expert talk in NSCLC&rdquo CME Organized by Novartis Oncology, Hyderabad on June 13, 2017. &ldquo Radiotherapy in Retinoblastoma&rdquo at Retinoblastoma Networking Workshop, LVPEI,
Hyderabad from June 10-12, 2017. &ldquo Breast&rdquo at Best of ASTRO 2017,
Vizag on May 13-14, 2017. &ldquo Bilateral Breast using TomoTherapy&rdquo at Accuray User& s Meeting,
Bangalore on April 22-23, 2017. &ldquo Re-irradiation When and how to?&rdquo Session on &ldquo
Novel therapies Part III Molecular Neuro-Oncology Resistance and re-treatment&rdquo at 9th annual Conference of Indian Society of Neuro-Oncology (ISNOCON 2017), Bangalore from January 10-12, 2017. &ldquo Crossfire: Surgery vs Radiotherapy for high risk early Prostate Cancer&rdquo at First Prostate Cancer Symposium PRiSM 2016 organized by Dr. Reddy& s Laboratories Ltd. ,
Hyderabad from December 17-18, 2016. &ldquo Optimal treatment for oligo brain metastasis: Role of SRS&rdquo Session on &ldquo CNS Debate (Debator – 1 in favour of SRS)&rdquo at 39th AROICON 2016,
Bhubaneshwar from November 24-27, 2016. &ldquo Plaque Brachytherapy for Ocular Tumor&rdquo Session on &ldquo Paediatrics Oncology&rdquo at 39th AROICON 2016, Bhubaneshwar from November 24-27, 2016. &ldquo Ocular Brachytherapy&rdquo at AROICON – 2016, TN-PY Chapter,
Chennai on October 15-16, 2016. &ldquo Cancer Management Paradigm Shift&rdquo at Recent Advances in Surgical Procedures,
Dubai UAE on September 30, 2016. &ldquo Organ Preservation Protocols our experience&rdquo at FHNO South-East Zonal CME on Ca. Larynx, Organized by Apollo Cancer Institute in association with AOI Hyderabad & Telangana State Branches, Hyderabad on September 3, 2016. &ldquo Brachytherapy in Ophthalmic
Tumors&rdquo at 6th Annual Conference of IBSCON 2016, Hyatt Regency, Chennai on August 27-28, 2016. &ldquo Radiotherapy in Elderly Breast Cancer&rdquo Session on &ldquo Breast Cancer in Elderly: Coming of Age&rdquo at Navigating Clinical Conundrums in Breast Cancer, Mumbai on August 20-21, 2016.
&ldquo Overall Scenario of Cancer in India & Prevention & Cure&rdquo Session on &ldquo Cancer Prevention & A Healthy Lifestyle&rdquo at CII Young Indians, Hyderabad on July 28, 2016.
Invited as a Perspective for &ldquo Hard Talk – Perspective in adopting new data&rdquo Session on &ldquo Irradiating the axilla- Why exchange one toxicity for another especially when prognostication is at stake?&rdquo at Controversies in Clinical Oncology, TMH,
Kolkata from July 22-24, 2016. &ldquo New Technology Does it have an impact in the management of Gynaec Cancers Cost vs benefit&rdquo at CME on &ldquo Oncology and Robotics in Gynecology&rdquo , organized by OGSH in association with Apollo Hospitals, Hyderabad on July 16, 2016.
Invited as a Panelist for the Panel discussion on &ldquo Case Based Discussion in Rare Solid Tumors&rdquo at 3rd Mid Term National Conference of Pediatric Hematology Oncology, Hyderabad on July 9-10, 2016.
&ldquo Role of Radiation Oncologist in the Management of Ophthalmic Tumors&rdquo , at EYE CANcer 2016, LVPEI, Hyderabad on July 9, 2016.
Moderator for the Panel Discussion on &ldquo Lung Cancer Non-small Cell / Small Cell / Other&rdquo at Best of ASCO 2016, HICC, Hyderabad on July 1-3, 2016.
Moderator for the Session on &ldquo Each Expert Group Propose Recommendations&rdquo at CME on &ldquo Consensus Recommendations of Expert Group for Management of Advanced Cervical Cancer in India&rdquo , organized by Roche Oncology, Hyderabad on June 18, 2016. &ldquo Cancer Management A Paradigm Shift&rdquo , CME Program on Post Thrombotic Syndrome and Varicose Vein Ulcer Management organized by Apollo Hospitals, Hyderabad in association with IMA, East at Hyderabad on April 24, 2016.
Moderator for the Panel Discussion &ldquo Decision Making for Adjuvant Radiation&rdquo Session on &ldquo Breast Cancer 1: Early Breast Cancer&rdquo at 12th International Conference of Asian Clinical Oncology Society (ACOS), New Delhi from April 8-10, 2016.
Invited as a Chairperson for &ldquo Direction of Current Neuro-oncology Research&rdquo at ISNOCON 2016, Hyderabad from April 1-3, 2016.
Invited as a Panelist for the Head and Neck Cancer& Session on &ldquo Therapeutic Decision Making in Borderline and locally advanced HNSCC&rdquo at 34th ICON (Joint Conference of Indian Cooperative Oncology Network and Molecular Oncology Society, Hyderabad from March 11-13, 2016.
Invited as a Panelist for the Lunch Symposium on &ldquo Challenges in delivery of chemoradiation in Lung Cancer&rdquo at 34th ICON (Joint Conference of Indian Cooperative Oncology Network and Molecular Oncology Society, Hyderabad from March 11-13, 2016. &ldquo Did the higher accuracy in treatment delivery translate into noticeable Clinical Improvements?&rdquo at AROI West Bengal Annual State Conference,
Kolkata on February 20-21, 2016. &ldquo Cancer Management Paradigm Shift&rdquo at Indian Medical Association (IMA) CME, Hyderabad on February 13, 2016. Invited as a Panelist for the Panel Discussion on &ldquo Nanotechnology based Paclitaxel in Clinical Practice&rdquo at SUN Oncology BEVETEX Symposium, Hyderabad on January 2, 2016.

Research

Research

A retrospective analysis of irinotecan and bevacizumab combination therapy in recurrent high-grade glioma and glioblastoma multiforme: Single Institute experience – International Journal of Neuro-Oncology; 2022; Vol. 5(1), Pg: 1-9.
Primary Macular Retinoblastoma: Clinical Presentation and Treatment Outcomes – Journal of VitreoRetinal Diseases; Aug 2022; Vol. 6(5), Pg: 367-373.
Does Multimodal Treatment improve Eye and Life Salvage in Adenoid Cystic Carcinoma of the Lacrimal Gland – The American Society of Ophthalmic Plastic and Reconstructive Surgery; 2021.
Use of Bevacizumab in Advanced Ovarian Cancer: Consensus from an Expert Panel Oncologists – Indian Journal of Gynecologic Oncology; 2021.
Histopathology – Guided management of Ocular surface squamous neoplasia with corneal stromal or scleral invasion using Ruthenium – 106 Plaque Brachytherapy – British Journal of Ophthalmology, Dec 2021; Vol. 10, Pg: 1-6.
Outcomes of Tandem Intravitreal Chemotherapy for Refractory Vitreous Seeds in Retinoblastoma – AIOC 2021 Proceedings.
Use of Bevacizumab in Advanced Ovarian Cancer: Consensus from an Expert Panel Oncologists – Indian Journal of Gynecologic Oncology, Feb 2021; Vol. 19(25), Pg: 1-8.
Stereotactic Radiosurgery for Single or Oligometastatic Brain Lesions: A single Institutional Experience – Intl. Journal of Neuro-Oncology, Dec 2020; Vol. 3(2), Pg: 93-97.
Second Primary Tumors in Retinoblastoma Survivors: A study of 7 Asian Indian patients – International Ophthalmology, Dec 2020; Vol. 40(2), Pg: 3303-3308.
Ocular Oncology Practice Guidelines during COVID-19 Pandemic – An Expert Consensus – Indian Journal of Ophthalmology, July 2020; Vol. 68(7), Pg: 1281-1291.
Choosing Wisely for Cancer Care in India – Indian Journal of Surgery, February 2020; Vol. 82(1), Pg: 6-8.
Preservation of Retinoblastoma Group E Eyes with Neovascular Glaucoma using Intravenous Chemotherapy: Risk factors and outcomes – British Journal of Ophthalmology, Dec’ 2019; Vol. 103(12), Pg: 1856-1861.
Presented a Poster on “Selective Ophthalmic Artery Chemotherapy as Primary treatment in advanced Stages of Retinoblastoma : A Prospective Study – European Society of Radiology 2019; Poster No.: C-1856; DOI: 10.26044/ecr2019/C-1856; Pg: 1-13.
Choosing Wisely India: Ten low-value or harmful practices that should be avoided in Cancer Care – DOI Handbook, March 2019; Pg: 1-6.
Reducing Gender Disparity in Oncologists of India: An opportunity to Address Workforce Challenges – Journal of Clinical Oncology, August 2018; Pg: 1-5.
Utilization of a Web-based Conferencing Platform to improve Global Radiation Oncology Education and Quality – Proof of Principle through implementation in India – International Journal of Radiation Oncology, July 2018; Vol. 103; No. 1; Pg: 276-280.
Eye Salvage in diffuse Anterior Retinoblastoma using Systemic Chemotherapy with Periocular and Intravitreal Topotecan – Journal of American Association for Pediatric Ophthalmology and Strabismus, April 2018; Vol. 22; No. 3.
Melanorrhea: Noncontiguous spread of palpebral Conjunctival Melanoma to the Nasolacrimal Duct – Indian Journal of Ophthalmology, February 2018; Vol. 66; No. 2; Pg. 302-303.
Re-irradiation in Central Nervous System Tumors – Journal of Current Oncology, Jan-June 2018; Vol. 1; Issue. 1; Pg. 40-42.
Radiobiology of Re-irradiations – Journal of Current Oncology, Jan-June 2018; Vol. 1; Issue. 1; Pg. 35-39.
Management of Retinoblastoma with Extraocular tumor Extension – Community Eye Health Journal, 2018; Vol. 31; No. 101; Pg. 18-19.
Outcomes and Prognostic factors in re-irradiation of Intracranial Gliomas: Single Institution Experience – Annals of Oncology, November 2017; Vol. 28; No. 10.
Intravitreal Topotecan in the Management of Refractory and Recurrent Vitreous seeds in Retinoblastoma – British Journal of Ophthalmology, August 2017; Vol. 102; No. 4.
Aqueous Deficient Dry Eye Syndrome Post Orbital Radiotherapy: A 10-year Retrospective Study – Translational Vision Science & Technology, June 2017; Vol. 6; No. 3; Article 19; Pg. 1-9.
Clinical Presentation and Outcomes of Stage III or Stage IV Retinoblastoma in 8 Asian Indian Patients – Journal of Pediatric Ophthalmology & Strabismus, 2017; Vol. 54; No. 3; Pg. 177-184.
Asian Expert Recommendation on Management of Skin and Mucosal effects of Radiation, with or without the addition of Cetuximab or Chemotherapy, in treatment of Head & Neck Squamous Cell Carcinoma – BMC Cancer, 2016; Vol. 16; No. 42; Pg. 1-13.
Therapy and Lacrimal Drainage System Toxicity: Nasal Localization Studies using Whole body Nuclear Scintigraphy and SPECT-CT – The American Society of Ophthalmic Plastic and Reconstructive Surgery 2014; Vol. XX; No. XX; Pg. 1-4.
Ophthalmologic Pathology: SY20-2 What is your Diagnosis? – Royal College of Pathologists of Australia, Taylor & Francis October 2014; Vol. 46 (2); Pg. S30
Orbital Alveolar soft-part Sarcoma: Clinico-pathological profiles, management and Outcomes – Journal of Cancer Research and Therapeutics; April-June 2014; Vol. 10; Issue. 2; Pg. 294-298.
Management and Outcome of Retinoblastoma with Vitreous Seeds – American Academy of Ophthalmology Feb 2014; Vol. 121 (2); Pg. 517-524
Lacrimal Surgery Glorious past, exciting present era and the audacity of hope for a brilliant future – Saudi Journal of Ophthalmology 2014; Vol. 28; Pg. 1-2.
Gene Expression Signature of Putative Cancer Stem Cells in Retinoblastoma Y79 Cell Line – Investigative Ophthalmology & Visual Science 2013; Vol. 54; E-Abstract 3968.
Evolution of Response to Carboplatin in Putative Cancer Stem Cells of Retinoblastoma Y79 Cell Line – Investigative Ophthalmology & Visual Science 2013; Vol. 54; E-Abstract 1256.
Distant metastatic Retinoblastoma without Central Nervous system involvement – Indian Journal of Ophthalmology July 2013; Vol. 61(7); Pg. 357-359.
Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker – Histopathology May 2013; Vol. 62(6); Pg. 840-846.
Primary Intraocular Malignant Extrarenal Rhabdoid tumor: a Clinicpathological Correlation – Journal of Pediatric Ophthalmology and Strabismus April 2013; Vol. 50; Pg. e18-20.
Distant Metastatic Retinoblastoma without Central Nervous System involvement – Indian Journal of Ophthalmology April 2013; PubMed ID – 23548316.
Optic Nerve Meningeal Hemangiopericytoma: A Clinicopathological Case Report – Survey of Ophthalmology January 2013; pii: S0039-6257(12)00248-2. doi: 10.1016; PubMed ID – 23294915.
Radiation Oncology in 21st Century – Changing the Paradigms – Apollo Medicine June 2012; Vol. 9; No. 2; Pg. 115-125.
Orbital Plasmablastic Lymphoma: A Clinico-Pathological Correlation of a rare disease and review of Literature – Clinical Ophthalmology (Auckland, N.Z.) 6: 2012; Pg. 2049-2057.
Evaluation of HER-2/neu status in Breast Cancer Specimens using Immunohistochemistry (IHC) & Fluorescence in-situ hybridization (FISH) assay – Indian Journal of Medical Research March 2012; Pg. 312-317.
Establishing Human Lacrimal Gland Cultures with Secretory Function – PLoS One. 2012; Vol. 7(1); e29458.
High Dose Rate Interstitial Brachytherapy in Carcinoma Eyelid: Can it be a Primary treatment Modality? – Journal of Cancer Research and Therapeutics Oct-Dec 2011; Vol. 7(4); Pg. 498-499.
First Indian Experience with Shaped Beam Radiosurgery of Cranial and Spinal Lesions on Novalis-Tx Linear Accelerator with Exac Trac 6D Robotic Couch – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1166.
Set-up Accuracy with Frameless Radiosurgery of Intracranial Lesions using Exac Trac 6-D Robotic Couch on Novali-Tx Linear Accelerator – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1147.
Comparison of Intensity Modulated Stereotactic Radiosurgery with Conventional Stereotactic Conformal Beam Radiosurgery in Vestibular Schwannomas – 10th International Stereotactic Radiosurgery Society Congress “Brain & Body Radiosurgery”, Paris 2011; Pg. 1003.
The New Radiation Technology and Techniques – Does it Matter in Gynec Cancer? – Annals of IMA Academy of Medical Specialities 2011; Pg. 49-53.
Evaluation of Human Lacrimal Gland Cultures for Secretory Function and Putative Stem Cells – Indian Eye Research Group (IEGR) 2011; Pg. 84.
Orbital Retinoblastoma: Where do we go from here? – Journal of Cancer Research and Therapeutics May 2011; Vol. 7(1); Pg. 11-14.
Cultivation and Characterization of Human Lacrimal Gland Cells for Potential Clinical Application – Indian Eye Research Group (IERG) 2010; Vol. 1; Pg. 80.
Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors – Indian Eye Research Group (IERG) 2010; Vol. 1; Pg. 110-111.
Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors – Shifting Paradigms in Head and Neck Oncology (IFHNOS) 2010; Vol. 1; Pg. 233
Orbital Retinoblastoma: Present status and future challenges – A review – Saudi Journal of Ophthalmology 2010, Vol. 25(2); Pg. 159-167.
Largest series of orbital Schwannoma: Clinical manifestations and outcomes (Abs) – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 131.
Genotype-Phenotype and Clinical Correlation in Retinoblastoma (Abs) – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 129.
RBI Gene Mutations in Ratinoblastoma and its clinical correlation – Saudi Journal of Ophthalmology May 2010; Vol. 24; Pg. 119-123.
Ruthenium 106 Plaque Brachytherapy: Indications and Outcomes in Ocular Tumors (Abs) – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 121.
A typical presentation of Ciliary body Medulloepithelioma (Abs) – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 116.
Histopathology of Retinoblastoma after primary Chemotherapy (Abs) – Saudi Journal of Ophthalmology 2010; Vol. 24; Pg. 100.
Evisceration in unsuspected Intraocular Tumors – Archives of Ophthalmology March 2010; Vol. 128(3); Pg. 372-379.
Histopathologic changes in Uveal melanoma after Ruthenium 106 Brachytherapy – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S98
Cultivation and characterization of Lacrimal and Salivary Gland Cells for Potential Clinical application – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S98
Role of HPV, Cell cycle markers and epigenetic modifications at DNMT3L region in Ocular surface Squamous Neoplasia – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S97
HPV for Cervical Cancer Screening: Is the era of the Molecular Pap Smear upon us? – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S97
Ruthenium 106 Plaque Brachytherapy : Indications and outcome in Ocular Tumors – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S88-89.
Cervical Cancer Screening: Role of Serotyping of HPV as bridge of Cytopathology and Molecular typing? – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S75
Genotype and phenotype correlation analysis in Retinoblastoma – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S75
Sebaceous Carcinoma of the Eyelid Metastasizing to the Lacrimal Sac after 5 years – Orbit (Amsterdam, Netherlands) October 2009; Vol. 28(5); Pg.309-312.
Histopathology of retinoblastoma after primary chemotherapy – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 296.
Orbital Schwannoma: Clinical manifestations and outcomes – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 146.
Periocular Carboplatin Injection in the management of Retinoblastoma with Diffuse Vitreous Seeds – The International Society of Ocular Oncology ISOO Meetings, Cambridge 2009; Pg. 277.
A typical presentation of Ciliary body Medulloepithelioma – Proceedings of the XIV International Congress of Ocular Oncology, Cambridge 2009; Pg. 46.
Management of Ophthalmic Tumors – Role of Chemotherapy and Radiation therapy – Surgical Atlas of Orbital Diseases July 2009; Chapter. 25; Pg. 307-318.
Histopathologic Risk factors in Retinoblastoma in India – The American Journal of Surgical Pathology May 2009; Vol. 33(5); Pg. 788-798.
Extramedullary Leukemia in Children presenting with Proptosis – Journal of Hematology & Oncology 2009; Vol. 2; Pg. 4.
Retinoblastoma – Advances in Management – Apollo Medicine Sept. 2008; Vol. 5; No. 3; Pg. 183-189.
Proptosis as a Manifestation of Acute Myeloid Leukemia – Pediatric Clinics of North India 2008.
Clinical Profile and Treatment Outcome of Orbital Rhabdomyosarcoma – Experience of An Ocular Oncology Center – Best Paper of Orbit/Plastic Surgery Session – 1 in AIOC 2007 Proceedings, Pg. 417-418.
The Role of Subconjunctival Carboplatin in the Treatment of Advanced Cases of Retinoblastoma – A series of First Ten Patients – Best Paper of Pediatric Ophthalmology Session in AIOC 2007 Proceedings, Pg. 36-40.
Metastasis to the Eye and Orbit from Renal Cell Carcinoma – A Report of Three Cases and Review of Literature – Survey of Ophthalmology Mar-Apr 2007; Vol. 52(2); Pg. 213-223.
Systemic Metastasis Following Hyphema Drainage in an Unsuspected Retinoblastoma – Journal of Pediatric Ophthalmology and Strabismus Mar-Apr 2007; Vol. 44; Pg. 120-123.
Orbital Embryonal Rhabdomyosarcoma in association with Neurofibromatosis type 1 – Ophthalmic Plastic and Reconstructive Surgery Mar-Apr 2007; Vol. 23(2); Pg. 147-148.
Acute Respiratory Distress Syndrome due to Strongyloides Stercoralis in Non-Hodgkin’s Lymphoma – The Indian Journal of Chest Diseases & Allied Sciences Jan-Mar 2006; Vol. 48(1); Pg. 67-69.
Ruthenium-106 Plaque Brachytherapy for the treatment of Diffuse Choroidal Haemangioma in Sturge-Weber Syndrome – Indian Journal of Ophthalmology Dec. 2005; Vol. 53(4); Pg. 274-275.
Neoadjuvant Chemotherapy in the Management of Sebaceous Gland Carcinoma of the Eyelid with Regional Lymph Node Metastasis – Ophthalmic Plastic and Reconstructive Surgery July 2005; Vol. 21(4); Pg. 307-309.
Concurrent Chemo Radiotherapy followed by Intraluminal Brachytherapy in non-metastatic carcinoma oesophagus – Journal of Clinical Oncology, ASCO Annual Meeting Proceedings, Vol. 22, 14S (July 15 Supplement), 2004 : 4201.
Clinicopathologic findings in Choroidal Melanomas after failed Transpupillary Thermotherapy – American Journal of Ophthalmology March 2004; Vol. 137(3); Pg. 594-595; author reply 595-596
Histopathology of Retinoblastoma after Primary Chemotherapy – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 94.
Retinoblastoma in Older Children – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 91.
Adenoid Cystic Carcinoma of the Lacrimal Gland in Asian-Indian Population – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 84.
Management of Orbital Retinoblastoma – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 51.
A Typical Presentation of Retinoblastoma – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 44.
A Case Report of Unknown Orbital Tumor – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 40.
Neoadjuvant Chemotherapy in the Management of Sebaceous Gland Carcinoma – Proceedings of the XI International Congress of Ocular Oncology, Hyderabad, India January 2004; ICOO Secretariat & L.V. Prasad Eye Institute; Pg. 38-39.
Thermochemotherapy in hereditary Retinoblastoma – British Journal of Ophthalmology Nov. 2003; Vol. 87(11); Pg. 1432.
Retinoblastoma – Asian Journal of Pediatric Practice 2003.
Retinoblastoma Management – Current Concepts – Chakshu 2003.
Current Management of Retinoblastoma – Eye Care 2003; Pg. 15-19.
Ultrasound guided Conformal Brachytherapy in Prostate Cancer – Journal of Radiotherapy and Oncology, Vol. 58(1) Pg. S109-S110 Proceedings of ISRO – ICRO 2001; 6th International Congress of Radiation Oncology, 30th Jan to 2nd Feb 2001 at Melbourne, Australia.
Low dose rate Intraluminal Brachytherapy following Concurrent Chemo-radiation in Non-metastatic Carcinoma Oesophagus – Journal of Clinical Radiotherapy and Oncology Jul-Dec 1997; Vol. 12(1-2); Pg. 32-35.
A prospective randomized study of the role of combination of Interferon and Radiation therapy in the management of locally advanced Carcinoma Cervix (Stage III B) – A Preliminary Report – Journal of Clinical Radiotherapy and Oncology Jul-Dec 1997; Vol. 12(1-2); Pg. 28-31.
An experience with low dose rate Intraluminal Brachytherapy following Concurrent Chemo radiation in Non-metastatic Carcinoma Oesophagus – Journal of Clinical Oncology 1997; Vol. 43(2).
A prospective randomized study of the role of combination of Interferon and Radiation therapy in the management of locally advanced Carcinoma Cervix (Stage III B) – A Preliminary Report – Journal of Clinical Radiotherapy & Oncology 1997; Vol. 43(2).
Assessment of Pain in Cancer Patients – Journal of Clinical Radiotherapy & Oncology March 1992; Vol. 7(1); Pg. 4-8.
Role of HBI in Symptomatic Multiple Bone Metastases – M.D. Thesis A.P. University of Health Sciences, A.P. Feb 1992.

Dr P Vijay Anand Reddy

Overview

Education

Experience

Doctor Awards

Research

Dr P Vijay Anand Reddy

Overview

Education

Experience

Doctor Awards

Dr P Vijay Anand Reddy

Research

Top Hospitals

Emergency

Apollo Lifeline International

Health Help Line

Request A Call Back

Request A Call Back